Access cutting-edge advanced cancer treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
The purpose of this study is to evaluate the safety and clinical activity of nivolumab and relatlimab in patients with microsatellite instability high (MSI-H) solid tumors refractory to prior PD-(L)1 therapy.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Check if you qualify for this advanced cancer clinical trial in Baltimore, MD
If you're searching for advanced cancer treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.